Revelation Biosciences Inc. (REVBW) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Revelation Biosciences In...

    NASDAQ: REVBW · Real-Time Price · USD
    0.01
    -0.00 (-10.71%)
    At close: Jun 09, 2025, 2:31 PM

    Revelation Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 6.5M 11.99M 5.25M 1.27M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a 0.00
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 49.5K 100.61K 160.3K 148.73K
    Total Current Assets
    		 6.57M 12.15M 5.41M 1.91M
    Property-Plant & Equipment
    		 56.33K 65.08K 90.13K 130.14K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 56.33K 65.08K 90.13K 130.14K
    Total Assets
    		 6.62M 12.21M 5.5M 2.04M
    Account Payables
    		 783.62K 1.36M 554.21K 596.26K
    Deferred Revenue
    		 n/a n/a 2.91M n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 294.32K 3.44M 3.28M 771.94K
    Total Current Liabilities
    		 1.91M 5.56M 4.45M 2.14M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a 554.21K 2.91M
    Total Liabilities
    		 1.91M 5.56M 4.45M 2.14M
    Total Debt
    		 n/a n/a n/a 16.75K
    Common Stock
    		 522.00 265.00 683.00 2.31K
    Retained Earnings
    		 -40.51B -25.47M -25.35M -14.52M
    Comprehensive Income
    		 n/a -0.00 n/a -0.00
    Shareholders Equity
    		 4.71B 6.65M 1.05M -99.47K
    Total Investments
    		 6.49B n/a n/a n/a

    Add to Watchlist